Frontiers in Oncology | Cancer Immunity and Immunotherapy

Case Report

Published on 28 Mar 2024

Optimal response to tislelizumab plus chemotherapy in metastatic triple-negative breast cancer: a case report and literature review

in Cancer Immunity and Immunotherapy

Yuxin Ma
Xinhong Shi
Kun Zhao
Shuyi Hu
Yue Shi
Yingying Jiang
Yiling Liu
Lin Lu
Yuting Chang
Fei Zhou

Frontiers in Oncology

doi 10.3389/fonc.2024.1328844

1,807 views

Study Protocol

Published on 28 Mar 2024

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion

in Cancer Immunity and Immunotherapy

Christopher Hackenbruch
Jens Bauer
Jonas S. Heitmann
Yacine Maringer
Annika Nelde
Monika Denk
Lisa Zieschang
Christine Kammer
Birgit Federmann
Susanne Jung

Frontiers in Oncology

doi 10.3389/fonc.2024.1367450

3,333 views
4 citations

Case Report

Published on 27 Mar 2024

Resection of unresectable hepatocellular carcinoma after conversion therapy with apatinib and camrelizumab: a case report and literature review

in Cancer Immunity and Immunotherapy

Xin-Liang Liu
Xiang-Ze Li
Yi-Fu Chu
Feng Liu
Hu Tian

Frontiers in Oncology

doi 10.3389/fonc.2024.1280805

1,515 views

Review

Published on 26 Mar 2024

Research progress of immunotherapy against anaplastic thyroid cancer

in Cancer Immunity and Immunotherapy

Jiaqian Chen
Zuixuan Xiao
Hongyan Wu

Frontiers in Oncology

doi 10.3389/fonc.2024.1365055

3,371 views

Review

Published on 20 Mar 2024

Prospects and challenges of CAR-T cell therapy combined with ICIs

in Cancer Immunity and Immunotherapy

Yufan Lv
Xinyu Luo
Zhuoyi Xie
Jieya Qiu
Jinsai Yang
Yuqi Deng
Rou Long
Guiyang Tang
Chaohui Zhang
Jianhong Zuo

Frontiers in Oncology

doi 10.3389/fonc.2024.1368732

5,057 views
18 citations

Case Report

Published on 14 Mar 2024

Neoadjuvant ipilimumab plus nivolumab therapy as a potential organ preservation strategy in mucosal melanoma: case report

in Cancer Immunity and Immunotherapy

Claire V. Ong
Wolfram Samlowski

Frontiers in Oncology

doi 10.3389/fonc.2024.1301424

2,000 views
5 citations

Original Research

Published on 14 Mar 2024

Machine learning models based on quantitative dynamic contrast-enhanced MRI parameters assess the expression levels of CD3+, CD4+, and CD8+ tumor-infiltrating lymphocytes in advanced gastric carcinoma

in Cancer Immunity and Immunotherapy

Huizhen Huang
Zhiheng Li
Dandan Wang
Ye Yang
Hongyan Jin
Zengxin Lu

Frontiers in Oncology

doi 10.3389/fonc.2024.1365550

1,577 views
2 citations

Review

Published on 13 Mar 2024

Animal model considerations for chordoma research: reproducing the tumor microenvironment in vivo with humanized mice

in Cancer Immunity and Immunotherapy

Beatrice Campilan
Christian Schroeder
Emilija Sagaityte
Jonathan Arditi
Owen P. Leary
Ziya L. Gokaslan
Patricia L. Zadnik Sullivan
Margot Martinez-Moreno

Frontiers in Oncology

doi 10.3389/fonc.2024.1330254

2,433 views
2 citations

Original Research

Published on 07 Mar 2024

Treatment response of advanced HNSCC towards immune checkpoint inhibition is associated with an activated effector memory T cell phenotype

in Cancer Immunity and Immunotherapy

Max Schumacher
Sina Beer
Emmanuelle Moraes Ribeiro
Fulya Korkmaz
Hildegard Keppeler
Rahel Fitzel
Estelle Erkner
Pia Radszuweit
Claudia Lengerke
Corina Schneidawind

Frontiers in Oncology

doi 10.3389/fonc.2024.1333640

2,287 views
1 citation

Original Research

Published on 07 Mar 2024

Cytotoxic response of tumor-infiltrating lymphocytes of head and neck cancer slice cultures under mitochondrial dysfunction

in Cancer Immunity and Immunotherapy

Maria do Carmo Greier
Annette Runge
Jozsef Dudas
Roland Hartl
Matthias Santer
Daniel Dejaco
Teresa Bernadette Steinbichler
Julia Federspiel
Christof Seifarth
Marko Konschake

Frontiers in Oncology

doi 10.3389/fonc.2024.1364577

2,184 views

Review

Published on 06 Mar 2024

Advances in research on the anti-tumor mechanism of Astragalus polysaccharides

in Cancer Immunity and Immunotherapy

Qian Yang
Dandan Meng
Qinyuan Zhang
Jin Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1334915

5,928 views
25 citations

Case Report

Published on 04 Mar 2024

Case report: Pembrolizumab as an alternative to atezolizumab following a severe infusion reaction

in Cancer Immunity and Immunotherapy

Seung Hyuk Lee
Hyeon Jong Kim
Hyun Jin Bang
Su Ji Park
Ji Eun Yu
Seung Woo Jeong
Woo Kyun Bae

Frontiers in Oncology

doi 10.3389/fonc.2024.1273043

2,094 views
1 citation

Review

Published on 27 Feb 2024

The role of immunotherapy sensitizers and novel immunotherapy modalities in the treatment of cancer

in Cancer Immunity and Immunotherapy

Guilherme Sacchi de Camargo Correia
Yujie Zhao
Rami Manochakian
Yanyan Lou

Frontiers in Oncology

doi 10.3389/fonc.2024.1336546

2,237 views
3 citations

Correction

Published on 27 Feb 2024

Corrigendum: Sequential PET/CT and pathological biomarker crosstalk predict response to PD-1 blockers alone or combined with sunitinib in propensity score-matched cohorts of cancer of unknown primary treatment

in Cancer Immunity and Immunotherapy

Youlong Wang
Qi Huang
Guanqing Zhong
Jun Lv
Qinzhi Guo
Yifei Ma
Xinjia Wang
Jiling Zeng

Frontiers in Oncology

doi 10.3389/fonc.2024.1376408

966 views

Original Research

Published on 27 Feb 2024

Seasonal influenza vaccines differentially activate and modulate toll-like receptor expression within the tumor microenvironment

in Cancer Immunity and Immunotherapy

Kajal H. Gupta
Eileena F. Giurini
Andrew Zloza

Frontiers in Oncology

doi 10.3389/fonc.2024.1308651

1,573 views
1 citation

Review

Published on 26 Feb 2024

Biopterin metabolism and nitric oxide recoupling in cancer

in Cancer Immunity and Immunotherapy

Gene Chatman Clark
Alan Lai
Aashri Agarwal
Zheng Liu
Xiang-Yang Wang

Frontiers in Oncology

doi 10.3389/fonc.2023.1321326

2,026 views
1 citation